InvestorsHub Logo
Post# of 172915
Next 10
Followers 33
Posts 2193
Boards Moderated 0
Alias Born 03/12/2015

Re: None

Wednesday, 05/24/2017 5:32:48 PM

Wednesday, May 24, 2017 5:32:48 PM

Post# of 172915
The PR released was aimed at shareholders yet was written like a PR. Investors read between the lines and see that it mentions they did a capital raise but I smell they will need more than they got. I am interested to see the filing for this to see just how many shares they converted for it. BMAK has been around on both sides of the level 2 telling us they are in full dilution mode currently. I would be willing to bet they know better now than to have BMAK run several days in a row and will now space it out over a few weeks. This PR still doesn't really give any sustenance just generalities. Guessing why it didn't really move. As for uplisting they need to hold above 4-5 dollars a share. With them diluting currently but stating they want a uplist seems counter intuitive. Of course they will state uplist because every shitty penny company says this. They have been saying that is there focus since they raised the AS back in 14'
Either way the timeline for FDA doesn't align with the end of the year so they are officially stating fluff. I wish all of you of course success. This company however will leave a blemish on Korenko's res.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News